You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.
You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen & Novartis are not responsible for and do not endorse or control the content contained on this third-party website.
Access to americanmigrainefoundation.org is not intended to provide medical advice or a referral to a particular physician;
Patients should discuss with their physician their experience with the patient’s medical condition and should then determine if the physician is qualified to perform the procedure;
Patients should discuss the risks and benefits of any procedure with their physician;
americanmigrainefoundation.org is an independent entity, and not affiliated with, or an agent of, Amgen Inc.
Amgen Inc. has not entered into any agreement with any doctor affiliated with americanmigrainefoundation.org to render any treatment or care to any patient, and has not evaluated the credentials, experience or expertise of any physician affiliated with, or referred through, americanmigrainefoundation.org.
AMGEN INC. MAKES NO EXPRESS, IMPLIED OR STATUTORY WARRANTIES OR REPRESENTATIONS (INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) AMERICANMIGRAINEFOUNDATION.ORG. TO THE MAXIMUM EXTENT PERMITTED BY LAW, AMGEN INC. AND ITS AFFILIATES ARE NOT RESPONSIBLE FOR AND EXPRESSLY DISCLAIM ALL LIABILITY, INCLUDING WITHOUT LIMITATION, FOR DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, AND SPECIAL OR OTHER DAMAGES ARISING FROM OR RELATED TO THE USE OF ANY SERVICES OFFERED BY AMERICANMIGRAINEFOUNDATION.ORG. BY ACCESSING AMERICANMIGRAINEFOUNDATION.ORG, YOU AGREE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW THAT YOU WILL HOLD AMGEN INC. AND ITS AFFILIATES HARMLESS FROM ANY AND ALL CLAIMS ARISING FROM OR IN CONNECTION WITH ANY ACT OR OMISSION OF AMERICANMIGRAINEFOUNDATION.ORG.
You are now leaving aimovig.com
You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen Inc. is not responsible for and does not endorse or control the content contained on this third-party website.
Click “OK” to proceed or “CANCEL” to return to aimovig.com
By clicking “OK” below, you acknowledge that you have read and reviewed the information contained within the Notice of Third-Party Site at the bottom of the page.
Who should not use Aimovig®? Do not use Aimovig if you are allergic to erenumab-aooe or any ingredients in
Who should not use Aimovig?Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.
Before starting Aimovig®, tell your healthcare provider (HCP) about all your
medical conditions, including if you are pregnant or plan to become
pregnant, breastfeeding or plan to breastfeed.
–
Important Safety Information
Who should not use Aimovig®? Do not use Aimovig® if you are allergic to erenumab-aooe or
any ingredients in
Aimovig®.
Before starting Aimovig®, tell your
healthcare provider (HCP)
about all your medical
conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to
breastfeed. Tell your HCP about all the medicines you take, including any prescription and
over-the-counter
medicines,
vitamins,
or herbal supplements. What are possible side effects of Aimovig®?
Aimovig® may cause serious side effects,
including:
Allergic reactions. Allergic reactions, including rash or swelling can
happen after
receiving
Aimovig®. This can
happen within hours to days after using Aimovig®. Call your HCP
or get emergency
medical help right away if
you
have
any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue
or throat, or
trouble
breathing.
Constipation with serious complications. Severe constipation can happen
after receiving
Aimovig®. In some cases
people have been hospitalized or needed surgery. Contact your HCP if you have severe
constipation or constipation associated with symptoms such as severe or constant belly pain, vomiting, swelling of belly or bloating.
High blood pressure. High blood pressure or worsening of high blood
pressure can happen
after
receiving Aimovig®. Contact your healthcare provider if you have
an increase in
blood pressure.
The most common side effects of Aimovig® are pain, redness,
or swelling at the
injection site and
constipation.
These are not all of the possible side effects of Aimovig®.
Call your HCP for
medical advice about side
effects.You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or
call 1-800-FDA-1088.Click here
for the full Prescribing Information and Patient
Product
Information.
Approved Use
Aimovig® is a prescription medicine used for the preventive
treatment of migraine
in
adults.
References: 1. Parsabiv®
(etelcalcetide) prescribing information, Amgen.
2. Data on file, Amgen; [Summary of
Clinical Efficacy; 2015]. 3. Alexander
ST, et al. Mol Pharmacol. 2015;88:853-865.
4. Data on file, Amgen; [Report
R20130052, 2014]. 5. Chen P, et al.
CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494.
6. Sensipar® (cinacalcet)
prescribing information, Amgen. 7. Ma JN,
et al. J Pharmacol Exp Ther. 2011;337:275-284.